" /> Vonlerolizumab - CISMeF





Preferred Label : Vonlerolizumab;

NCIt synonyms : RO7021608; Pogalizumab;

NCIt related terms : Anti-OX40 Monoclonal Antibody MOXR0916;

NCIt definition : An agonistic humanized monoclonal antibody against the receptor, OX40 (CD134), with potential immunostimulatory and antineoplastic activities. Upon intravenous administration, vonlerolizumab selectively binds to and activates OX40, by mimicking the action of endogenous OX40 ligand (OX40L). OX40 activation induces proliferation of effector T-lymphocytes and inhibits the activity of regulatory T-cells. In the presence of tumor-associated antigens (TAAs), this may promote an immune response against the TAA-expressing tumor cells. OX40, a cell surface glycoprotein and member of the tumor necrosis factor (TNF) receptor superfamily, is expressed on T-lymphocytes and provides a co-stimulatory signal for the proliferation and survival of activated T-cells.;

UNII : C78148TF1D;

CAS number : 1638935-72-4; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1638935-72-4 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : MOXR0916; RG-7888; RG 7888;

NCI Metathesaurus CUI : CL474130;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.